viernes, 2 de agosto de 2019

Medical News | Medical Articles: Ensuring safer and effective pharmaceutical formulations by XRD

Medical News | Medical Articles

 
 August 2, 2019 
 Pharmacy / Pharmacology 
 The latest pharmacy / pharmacology news from News Medical 
 #ALT#Ensuring safer and effective pharmaceutical formulations by XRD

From drug discovery and preformulating studies to scaling up in the manufacturing process in the plant and finally through QA/QC validation, X-ray diffraction (XRD) is a gold standard method in the determination of polymorphic and salt screening, percentage of crystallinity and stability/reactivity studies of the final API.

Register for the Webinar
 
 
  KeysightPipette+ Smarter, Connected Pipetting
 
Don't miss this opportunity to learn more about Pipette+. Its award-winning design provides smart connected pipetting using Andrew Alliance Bluetooth electronic pipettes, co-developed with, and manufactured by Sartorius.
 
Find Out More
 
 
 
  KeysightAdvancing the Development of Cannabinoid-derived Pharmaceuticals
 
The International Cannabinoid-Derived Pharmaceuticals Summit is returning this September to provide the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals. This event is the first of its kind and will take place September 10-12, 2019, in Boston, MA. 
 
Learn More
 
 
 Using LIMS to Comply with Pharmaceutical Regulations
 
Using LIMS to Comply with Pharmaceutical RegulationsIn order to discuss compliance with Part 11, Annex 11, and recent regulatory guidances data integrity and temporary memory, some basic information about LabVantage software functionality and some assumptions about the deployment and use of LabVantage software in a customer setting.
 
 
 Resveratrol shows promise for anxiety and depression
 
Resveratrol shows promise for anxiety and depressionA new study has shown that the compound resveratrol found in red wine demonstrates stress relieving effects in anxiety and depression. This could be due to resveratrol’s ability to control an enzyme in the brain that is liked to stress say the researchers from the University at Buffalo in collaboration with Xuzhou Medical University in China.
 
 
 New drug provides hope for patients with Duchenne muscular dystrophy
 
New drug provides hope for patients with Duchenne muscular dystrophyDuchenne muscular dystrophy (DMD) is a genetic, neuromuscular disease in which a patient lacks dystrophin, a structural protein present within muscle cells. This leads to inflammation and necrosis of muscles and gradual replacement of muscle tissue with fat and fibrous tissues resulting in muscle weakness.
 
 
 New leukemia treatment developed from common wild flower
 
New leukemia treatment developed from common wild flowerResearchers at Birmingham University have discovered how to turn a compound from a common wildflower called Feverfew into a new treatment for cancer. The team found a way to extract the naturally-occurring substance, called parthenolide, from the plant’s leaves and modify it so that it could destroy chronic lymphocytic leukemia (CLL) cells.
 
 
 Computer-generated flu vaccine enters clinical trials in the US
 
Computer-generated flu vaccine enters clinical trials in the USA seasonal flu vaccine has been developed at Flinders University in South Australia and is set to be tested in clinical trials in the US. The vaccine has been created with artificial intelligence and scientists claim that it is more effective than the traditional seasonal flu vaccine.
 
 
 Researchers publish review on serial femtosecond crystallography
 
Researchers publish review on serial femtosecond crystallographyResearchers from the Moscow Institute of Physics and Technology have published a review on serial femtosecond crystallography, one of the most promising methods for analyzing the tertiary structure of proteins. This technique has rapidly evolved over the past decade, opening new prospects for the rational design of drugs targeting proteins previously inaccessible to structural analysis. The article came out in the journal Expert Opinion on Drug Discovery.
 

No hay comentarios:

Publicar un comentario